Neurochem to Change Name and Ticker; Stock Up
Neurochem Inc. (NRMX) shares were up more than 17% on Tuesday morning as shareholders settle in at the company's annual and special meeting in downtown Montreal where they will usher in a new era for the company.
Shareholders will be asked to officially adopt Neurochem's new name, BELLUS Health Inc., which it expects to start using on April 21, 2008, together with the new stock ticker symbols [TSX/BLU, BLUS/NASDAQ].
Neurochem will also present the launch activities that are in preparation for VIVIMIND [TM], the first branded natural health product to be marketed by its new, wholly-owned, nutraceutical subsidiary, OVOS Natural Health Inc., to protect memory function.
Shareholders will also learn that Neurochem has regained full ownership rights and control on eprodisate (KIACTA [TM]) from Centocor Inc., a wholly-owned subsidiairy of Johnson and Johnson (JNJ), for the prevention and treatment of Amyloid A [AA] amyloidosis. http://seekingalpha.com/article/72464-neurochem-to-change-name-and-ticker-stock-up?source=yahoo